Importantly, longitudinal increases in 50 kDa proNGF levels in plasma over 1 year correlated to prospective cognitive decline over the subsequent 2 years (Iulita and Cuello, 2016), demonstrating a potential value of NGF-related biomarkers in identifying incipient cognitive decline in this population. The gene discussed is NGF; the disease is Mental deterioration.